Biography:

In the past C. Visentini has collaborated on articles with G. Rioli. One of their most recent publications is 1466 – Complementary and alternative medicines (cams) in psychiatry: the opinion of mental health professionals. Which was published in journal European Psychiatry.

More information about C. Visentini research including statistics on their citations can be found on their Copernicus Academic profile page.

C. Visentini's Articles: (2)

1466 – Complementary and alternative medicines (cams) in psychiatry: the opinion of mental health professionals

BackgroundIn a demographic survey in 2005, 13.6% of Italians admitted to have taken CAMs during the 3 years before. A study on hospitalized patients for psychiatric reasons highlighted that 63% of them used CAM in the previous year and 79% did not mention this to their psychiatrists.ObjectiveTo collect the opinions about the use of CAMs in psychiatry among a group of psychiatrists and nurses working in a Mental Health Centre.AimTo investigate knowledge, opinions and experiences on CAMs.MethodsA mixed qualitative-quantitative method was used: 2 focus groups were conducted in June 2011, involving 12 professionals of one Mental Health Community Centre in Modena, Italy. The audio-recordings of the focus groups were analyzed by 2 researchers, who identified the main themes with an inductive method. The participants were finally asked to fill in a respondent validation questionnaire.ResultsFour main themes were developed:1)advantages, and2)disadvantages in the use of CAMs,3)patients’ and own experiences,4)variety of therapies under the CAM acronym.Among the pros, 75% of respondents agreed that CAMs allow a better global approach to the patient, 58% that CAMs may improve quality of life, 66% that conventional psychiatric therapies do not solve every situation. As to disadvantages, some professionals (medical doctors) expressed skepticism on CAMs.ConclusionsBeing realistic, open-minded and ready to listen and cooperate: this could be the best attitude towards patients who take CAMs.

EV0305Cardiovascular risk factors, anxiety symptoms and inflammation markers: Evidence of association from a cross-sectional study

IntroductionAnxiety disorders and Cardiovascular (CV) diseases, among the most common disorders in Western World, are often comorbid. A chronic systemic inflammatory state might be a shared underlining pathophysiological mechanism.AimsTo investigate the association between anxiety symptoms, CV risks factors and inflammatory markers in an outpatient sample.MethodsCross-sectional study. Inclusion criteria: outpatients aged ≥40 years, attending colonoscopy after positive faecal occult blood test, negative medical history for cancer. Collected data: blood pressure, glycaemia, lipid profile, waist circumference, BMI, PCR (C Reactive Protein), LPS (bacterial Lipopolysaccharide). Psychometric tests: HADS, TCI, IMSA, SF36. Statistical analysis performed with STATA13.ResultsFifty four patients enrolled (27 males, 27 females). Sixteen patients (30.19%) were positive for anxiety symptoms. Thirty-three patients (61.11%) had hypertension, 14 (25.93%) hyperglycaemia and 64.81% were overweight, with frank obesity (BMI≥ 30) in 11 subjects (20.37%). Anxiety symptoms were associated with low hematic HDL values (OR = 0.01; P = 0.01) and high concentration of triglycerides (OR = 0.023; P = 0.02) at the multiple regression model. At the univariate logistic analysis, anxiety was associated with LPS (OR = 1.06; P = 0.04).ConclusionsFurther evidence over the epidemiological link between common mental disorders and CV diseases was collected, with possible hints on pathophysiology and causative mechanisms related to inflammation. The importance of screening for anxiety and depression in medical populations is confirmed. Suggestions on future availability of screening tools based on inflammatory-related indicators should be the focus of future research.

Advertisement
Join Copernicus Academic and get access to over 12 million papers authored by 7+ million academics.
Join for free!

Contact us